renzapride has been researched along with sc 53116 in 1 studies
Studies (renzapride) | Trials (renzapride) | Recent Studies (post-2010) (renzapride) | Studies (sc 53116) | Trials (sc 53116) | Recent Studies (post-2010) (sc 53116) |
---|---|---|---|---|---|
70 | 12 | 2 | 20 | 0 | 3 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Flynn, DL; Goldstin, B; Gullikson, GW; Moormann, AE; Yang, DC | 1 |
1 other study(ies) available for renzapride and sc 53116
Article | Year |
---|---|
SC-53606, a potent and selective antagonist of 5-hydroxytryptamine4 receptors in isolated rat esophageal tunica muscularis mucosae.
Topics: 4-Aminobenzoic Acid; Animals; Benzamides; Bridged Bicyclo Compounds; Bridged Bicyclo Compounds, Heterocyclic; Carbachol; Esophagus; Imidazoles; In Vitro Techniques; Indoles; Male; Mucous Membrane; Muscle Contraction; Muscle, Smooth; para-Aminobenzoates; Pyrroles; Rats; Receptors, Cell Surface; Receptors, Serotonin; Serotonin Antagonists; Serotonin Receptor Agonists; Tropisetron; Tryptamines | 1993 |